AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi

AbstractBackground. Unplanned healthcare utilization events, including hospital readmissions and emergency room (ER) visits, are common in patients receivi

Chimeric antigen receptor (CAR) T cell therapy has shifted the therapeutic landscape of hematological malignancies in the last decade, and bispecific antibodies (BsAb) are an emerging treatment for th...

Diagnostic yield of blood cultures in febrile neutropenia—a real-world observational study from an academic medical center during blood culture bottle shortage

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy - Volume 5 Issue 1

Abstract. Bloodstream infections due to yeast are associated with a high mortality rate. There is a lack of data that evaluate the real-world sensitivity o

Invasive fusariosis is a rare entity that primarily affects patients with hematological malignancies and recipients of hematopoietic cell transplants. Cases of mold infections in chimeric antigen receptor T-cell (CAR-T) therapy recipients have seldom been reported (1–6). We herein present this case of invasive fusariosis managed with combination antifungal therapy. Additionally, we provide a succinct review of cases reported in existing literature.

Subscription and open access journals from Sage, the world's leading independent academic publisher.

In this narrative review, we explore the burden and risk factors of various herpesvirus infections in patients receiving chimeric antigen receptor T-cell (CAR-T) therapy or bispecific antibodies (BsAb...

A stomach bug sweeping the country has infected hundreds of patients in its path.

AbstractObjectives. To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify

The University of Oklahoma College of Medicine did a controlled test and showed the odds of infection-related readmissions were decreased in the RTM group by 76% at 30 days, 80% at 60 days and 68% at ...